MSRD Q2 Dinner: Attendees

This presentation will cover updates in CPPD disease epidemiology, classification criteria, and long-term outcomes in the joint and beyond the joint.

Speaker Bio:

Dr. Sara Tedeschi is a rheumatologist and clinical investigator at Brigham and Women’s Hospital, where she is Head of Crystalline Arthritic Diseases. She is Principal Investigator of the NIH-funded CRYSTALLIZE trial of colchicine versus placebo in CPPD disease. She co-led the development of the ACR/EULAR CPPD Disease Classification Criteria and serves as Co-Chair of the OMERACT CPPD Working Group. Dr. Tedeschi also serves on the American College of Rheumatology Quality of Care Criteria Subcommittee.

Who Should Attend:

Rheumatologists, fellows, residents, allied health professionals, and others interested in advancing rheumatology practice and patient care.

Dinner will be provided, and CME credit will be available.

Note: Cost is free for current MSRD members. Non-members will receive a $100 invoice prior to the dinner. 

If you are registering as an MSL or TLL, contact us at msrd@msrd.org. 

Parking

For your convenience, valet parking will be offered at the dinner. You must arrive in front of the Overlook entrance on Rye St, and use Cromwell St to get there. Use the map for help.